– UK, Bristol – Curtis Banks Group PLC (LON: CBP), one the UK’s leading SIPP providers, today announced the appointment of Peter Docherty to its Board of Directors as Interim CEO effective immediately, concurrent with David Barral reverting to the role of Non-Executive Chairman with effect from 1 February 2023.
“Peter is a highly capable senior executive with an impressive track record in leadership, transformation, operations and delivering results. He joins us at an exciting time as we work towards the completion of the acquisition by Nucleus. Having an experienced CEO at the helm is an important step in strengthening our leadership team and allows me to step back into my role as Non-Executive Chairman.” said Board Chairman, David Barral.
About Peter Docherty
Peter Docherty has over 20 years of experience in financial services, having most recently been the Chief Executive and MD of the Embark Platform during which time he led a significant increase in customers and assets under administration driven by organic growth and integration initiatives. Previous positions include the roles of CEO and CRO of Alliance Trust Savings Limited.
Peter Docherty said: “I am excited to join Curtis Banks at this critical juncture for the Company and following the announcement of the proposed acquisition by Nucleus. Curtis Banks has been at the forefront of retirement solutions in the UK wealth market and has the capabilities, competitive position, and talent to build momentum and capitalise on the opportunities that exist in its core market segments. I am delighted to lead the business through the next stage of its growth journey.”
For more information: https://www.curtisbanks.co.uk/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.